Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases

Overview of attention for article published in BMC Psychiatry, June 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

blogs: 1 blog
twitter: 3 X users

patent: 1 patent

Citations

dimensions_citation: 104 Dimensions

Readers on

mendeley: 122 Mendeley

Summary Blogs X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

SUSTAINED RELEASE OLANZAPINE FORMULATIONS

Application EP-4331570-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.